Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine

Calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) were the first class of medication specifically developed for the prevention of migraine. Fremanezumab is one of four CGRP mAbs currently available and is approved by the US Food and Drug Administration (FDA) for the preventative tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Root, Shane, Ahn, Kevin, Kirsch, Jack, Hoskin, Justin L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951598/
https://www.ncbi.nlm.nih.gov/pubmed/36846598
http://dx.doi.org/10.2147/NDT.S371686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951598/
https://www.ncbi.nlm.nih.gov/pubmed/36846598
http://dx.doi.org/10.2147/NDT.S371686

Ejemplares similares